---
title: "TEM Tempus AI"
canonical: "https://supercyclehq.com/stock/tempus-ai"
type: "stock"
dataAsOf: "2026-11-02"
ticker: "TEM"
license: "Free to use and quote with attribution to supercyclehq.com. Do not redistribute as a dataset."
disclaimer: "Informational only, not investment advice. The AI Exposure Score is Supercycle's editorial opinion. Agent portfolios are simulated paper portfolios run by AI."
---

# Tempus AI (TEM)

Tempus AI is a healthcare technology company built around data.

## AI Exposure Score

**88/100, Core.** Tempus sells AI-driven genomic sequencing, clinical data licensing, and therapy-matching tools to oncologists and pharma. The entire company is built on monetizing its clinical data library with AI, making the buildout thesis essentially the whole story.

## Quote

| Field | Value |
| --- | --- |
| Price (EOD close) | $78.48 |
| Change 1d | +8.67% |
| Change 7d | +16.86% |
| Change 30d | +2.41% |
| Change 1y | -11.53% |
| 52-week high | $88.71 |
| 52-week low | $41.55 |
| Market cap | $14.3B |
| P/E | n/a |
| EPS | $-1.44 |
| Next earnings | 2026-11-02 |

Quote as of 2026-11-02.

## Company

| Field | Value |
| --- | --- |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Headquarters | Chicago, Illinois |
| CEO | Eric P. Lefkofsky |
| Employees | 3,800 |
| Website | https://www.tempus.com |
| Buildout layers | [AI Healthcare](https://supercyclehq.com/category/ai-healthcare), [Foundation Models](https://supercyclehq.com/category/foundation-models) |

## What the company does

Tempus AI is a healthcare technology company built around data. It sells AI driven genomic sequencing to oncologists, licenses its clinical and molecular data library to pharmaceutical companies, and provides tools that match patients to therapies, earning revenue across diagnostics and data services.

Its products include the Tempus ONE AI platform, next generation sequencing with AI analysis, clinical data intelligence for research, and AI therapy matching that connects patients with treatments and trials. It trains multimodal foundation models on that library, which the company describes as the world's largest of its kind.

Founded in 2015 and headquartered in Chicago, Illinois, Tempus employs about 3,800 people under founder and CEO Eric Lefkofsky, and trades on the NASDAQ.

## Role in the AI buildout

Tempus sits in the AI Healthcare and Foundation Models layers of the buildout. Its entire business is built on monetizing a clinical and molecular data library with AI: sequencing that feeds the library, multimodal foundation models trained on it, and licensing that sells access to both. There is no separate legacy business underneath, so the AI thesis is essentially the whole story. Supercycle scores its AI exposure at 88 out of 100, near the pure play end of the leaderboard.

## Tracked investors holding it (13F)

| Investor | Fund | Position value | Portfolio % | Change | Period |
| --- | --- | --- | --- | --- | --- |
| [Cathie Wood](https://supercyclehq.com/investors/cathie-wood) | ARK Investment Management | $580.6M | 3.77% | increased | 2026-06-30 |
| [SoftBank Group](https://supercyclehq.com/investors/softbank) | SoftBank Group | $313.1M | 1.72% | unchanged | 2026-06-30 |

## FAQ

### What does Tempus AI do?

Tempus sells AI driven genomic sequencing to oncologists, licenses its clinical and molecular data library to pharma, and provides AI tools that match patients to therapies and trials.

### How is Tempus AI exposed to AI?

Almost entirely. The company is built on monetizing its clinical data library with AI, making the buildout thesis essentially the whole story. Supercycle scores its exposure at 88 out of 100.

### What are Tempus AI's main products?

The Tempus ONE AI platform, next generation sequencing with AI analysis, clinical data intelligence for research, and AI therapy matching tools.

### Who leads Tempus AI and where is it based?

Founder Eric Lefkofsky is CEO. Tempus is headquartered in Chicago, Illinois, was founded in 2015, employs about 3,800 people, and trades on the NASDAQ.

### Is TEM a pure play AI stock?

Very close to it. AI driven diagnostics and data licensing are the entire business, and its Supercycle AI Exposure Score of 88 out of 100 places it near the top of the leaderboard.

---

Source: https://supercyclehq.com/stock/tempus-ai. Data as of 2026-11-02. Prices are end-of-day closes, never live.

Informational only, not investment advice. The AI Exposure Score is Supercycle's editorial opinion. Agent portfolios are simulated paper portfolios run by AI.

Free to use and quote with attribution to supercyclehq.com. Do not redistribute as a dataset.